I ran across this on a medical transcription-related website:
*****
     buspirone transdermal patch
In Phase III trials for the treatment of both anxiety and ADHD
(attention deficit hyperactivity disorder). {*filter*}buspirone, Bristol-
Myers Squibb's BuSpar? (buspirone HCl), is currently indicated for the
management of anxiety. The transdermal buspirone patch is being co-
developed and tested by Bristol-Myers Squibb and Sano Corporation. See
Sano Proprietary Products. Source: PR Newswire - 02/18/97.
*****
     An inveterate BuSpar user, I would love the dosing convenience and
reliability of a patch!!! I clicked on the links but nothing produced :(

     Does anyone have -any- information pertaining to this
investigational pharmaceutical product?  Any input would be appreciated!

Many thanks!

Sent via Deja.com http://www.***.com/
Share what you know. Learn what you don't.